He Du
Impact in
- Internal Medicine top 10%
- Venous Thromboembolism Diagnosis and Management
-
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Cancer, Hypoxia, and Metabolism
Papers in
-
- Circular RNAs in diseases 3
-
- Venous Thromboembolism Diagnosis and Management 8
- Co-authors
- Youwei Zhang (4 shared papers)Sanyuan Sun (3 shared papers)Wei Xiong (10 shared papers)Yunfeng Zhao (8 shared papers)Bi Chen (2 shared papers)Xuejun Guo (5 shared papers)Yanhua Liu (2 shared papers)Yuan Yuan (1 shared paper)
- Journals
- BMJ Open Respiratory Research (2 papers)Frontiers in Oncology (2 papers)Oxidative Medicine and Cellular Longevity (2 papers)Thrombosis Journal (2 papers)Journal of Molecular and Cellular Cardiology (1 paper)
- Partner nations
- ChinaJapanUnited States
In The Last Decade
He Du
25 papers receiving 320 citations
Peers
Comparison fields: 5 of 63
- Internal Medicine 31
- Cancer Research 107
- Oncology 86
- Immunology 61
- Molecular Biology 186
Countries citing papers authored by He Du
This map shows the geographic impact of He Du's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by He Du with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites He Du more than expected).
Fields of papers citing papers by He Du
This network shows the impact of papers produced by He Du. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by He Du. The network helps show where He Du may publish in the future.
Co-authors
The 25 scholars most cited alongside He Du, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 26 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 59 | |
| 2 | 2020 | 38 | |
| 3 | 2019 | 37 | |
| 4 | 2011 | 35 | |
| 5 | 2021 | 33 | |
| 6 | 2021 | 20 | |
| 7 | 2020 | 17 | |
| 8 | 2016 | 10 | |
| 9 | 2021 | 8 | |
| 10 | 2023 | 7 | |
| 11 | 2022 | 7 | |
| 12 | 2021 | 7 | |
| 13 | 2023 | 6 | |
| 14 | [Tumor microvascular density detected by anti-CD105 and anti-CD34 in hepatocellular carcinoma patients and its predictive value of tumor recurrence after liver transplantation]. | 2010 | 6 |
| 15 | 2016 | 5 | |
| 16 | Distinct Prognostic Values of the mRNA Expression of Glucose Transporters in Non-Small Cell Lung Cancer. | 2020 | 5 |
| 17 | 2019 | 4 | |
| 18 | 2023 | 3 | |
| 19 | 2023 | 3 | |
| 20 | 2020 | 3 |
About He Du
He Du is a scholar working on Molecular Biology, Internal Medicine, Cancer Research, Pulmonary and Respiratory Medicine and Cardiology and Cardiovascular Medicine, having authored 26 papers that have together received 323 indexed citations. Recurring topics across this work include Venous Thromboembolism Diagnosis and Management (8 papers), Cancer-related molecular mechanisms research (4 papers), Lung Cancer Treatments and Mutations (4 papers), Central Venous Catheters and Hemodialysis (4 papers), MicroRNA in disease regulation (3 papers), Circular RNAs in diseases (3 papers), Cancer, Hypoxia, and Metabolism (3 papers) and Acute Myocardial Infarction Research (3 papers). The work is most often cited by research in Internal Medicine (31 citations), Cancer Research (107 citations), Oncology (86 citations), Immunology (61 citations) and Molecular Biology (186 citations). He Du has collaborated with scholars based in China, Japan and United States. Frequent co-authors include Youwei Zhang, Sanyuan Sun, Wei Xiong, Yunfeng Zhao, Bi Chen, Xuejun Guo, Yanhua Liu, Yuan Yuan, Qian Zhang and Honggang Yu. Their work appears in journals such as BMJ Open Respiratory Research, Frontiers in Oncology, Oxidative Medicine and Cellular Longevity, Thrombosis Journal and Journal of Molecular and Cellular Cardiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.